R&D investments by 2,000 of the world’s largest companies grew 6.9% in aggregate in fiscal 2008, compared to 9.0% growth in fiscal 2008, according to the European Commission’s “2009 EU Industrial R&D Scoreboard.” The Scoreboard tracks R&D spending by 1,000 EU and 1,000 non-EU firms. The economic downturn’s effect on these industrial sectors is not […]
The United Arab Emirates plans to establish a government body to regulate food and pharmaceutical standards. The FDA will serve as the model for the body. The country follows Saudi Arabia as the second nation in the region to create such an agency. The agency will work closely with the country’s National Pharmaco-vigilance Center, plans […]
Chile’s Senate has approved the creation of the Environmental Ministry, which will be voted on by the parliament for final approval. The Ministry would consist of the Superintendent of Environmental Regulation for environmental monitoring and enforcement, and the Environmental Evaluation Services, which would conduct environmental impact studies. The legislation also establishes an environmental court that […]
India is an attractive location for the operations of not only the world’s largest drug companies, but mid-sized companies as well. To establish themselves in the country, many foreign firms have made acquisitions or set up small operations. Among the recent acquirers is Perrigo, which bought Vedants Drugs and Fine Chemicals this fall and plans […]
The EU is expanding its number of Biosafety-Level 4 laboratories (BSL-4). BSL-4 labs are designed for research on the most dangerous pathogens and incorporate extensive safety features. Eight new facilities are under construction or planned and will join the six labs that currently operate in Britain, Germany, Sweden and France. The new labs are needed […]
The Taiwan Food and Drug Administration (TFDA) will be inaugurated on January 1, 2010. Combining the operations of four existing agencies, it will have a staff of 500. The aim of the TFDA is to increase the export of pharmaceutical products and foreign investment by raising regulatory standards and increasing transparency. Source: Economist Intelligence Unit
The South Korean market for clinical lab products was estimated to be $250 million in 2008. Sales of In Vitro Diagnostic (IVD) products accounted for 95% of the market, and is expected to grow 3%–10% over the next three years. Imported products account for 80% of the IVD reagent market and 100% of IVD instrument […]
This month, the Russian government announced an investment of RUB 318 billion ($11 billion) in nanotechnology, building on RUB 94 billion in spending over the last two years. The goal is to create a self-sustaining industry by 2015 to offset the country’s dependence on oil revenue and foreign investment. Currently, Russian nano-enabled products account for […]
In September, China’s State Food and Drug Administration issued a draft of its revised Good Manufacturing Practices for drugs. The public will have until the end of November to make comments. The last GMP standards came into effect in 1999. The new GMP adds an appendix for blood products and expands the appendix addressing sterile […]
The growth in the number of researchers in developing countries is outpacing that in developed countries, according to the latest Science and Technology Survey by the United Nations Educational, Scientific and Cultural Organization (UNESCO) Institute for Statistics. The Survey also indicates that R&D spending by developing countries is growing faster than in developed countries due […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
